Cite
MLA Citation
A. Carter et al.. “CDK5 Activation Drives Pancreatic Neuroendocrine Tumorigenesis and is a Therapeutic Target.” HPB, vol. 23, n.d., pp. S58–S59. http://access.bl.uk/ark:/81055/vdc_100124369589.0x000025
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
A. Carter et al.. “CDK5 Activation Drives Pancreatic Neuroendocrine Tumorigenesis and is a Therapeutic Target.” HPB, vol. 23, n.d., pp. S58–S59. http://access.bl.uk/ark:/81055/vdc_100124369589.0x000025